Efficacy of Upadacitinib vs Dupilumab for Atopic Dermatitis
The safety and efficacy of upadacitinib vs dupilumab in adults with atopic dermatitis is assessed.
Atopic Dermatitis
Managing Itch in Atopic Dermatitis: Current and Potential Treatments
Treatment options, recent advances in the field, and potential treatments for atopic dermatitis are reviewed.
Social Media May Be Effective for Recruiting Patients With Atopic Dermatitis
Recruitment cost of participants with atopic dermatitis via social media and their characteristics are identified.
Severe Eczema Tied to Depression, Internalizing Behaviors in Children
Severe atopic dermatitis (AD) is associated with symptoms of depression and internalizing behaviors throughout childhood.
Relative Safety of Systemic Immunomodulatory Agents for Atopic Dermatitis
The risk of bacterial and opportunistic infection in patients with AD treated with systemic immunomodulatory agents is assessed.
Readmission Rates and Comorbidity Index for Atopic Dermatitis Patients
Longitudinal trends of 30-day readmissions of patients with atopic dermatitis are examined.
Atopic Dermatitis Improvements Seen in Very Young Treated With Dupilumab
The phase 3 trial evaluated dupilumab, in addition to standard of care low potency topical corticosteroids, in 162 patients aged 6 months to 5 years with uncontrolled moderate to severe atopic dermatitis.
Novel Topical Agent May Improve Dandruff
The efficacy of a topical ointment for the treatment of dry scalp and dandruff was evaluated.
Skin Clearance, Itch Improvement Seen With Lebrikizumab in Atopic Dermatitis Trials
Lebrikizumab is a novel humanized monoclonal antibody that selectively inhibits IL-13.
Tacrolimus Ointment Plus Dupilumab an Option for Facial Atopic Dermatitis
A novel study investigates the safety and effectiveness of tacrolimus ointment plus dupilumab for facial atopic dermatitis.
- Loading...
Loading...
Next post in Dermatitis
Loading... 
Loading...